Risk of disease in siblings of patients with hereditary hemochromatosis

被引:11
作者
Nelson, RL
Persky, V
Davis, F
Becker, E
机构
[1] Univ Illinois, Coll Med, Dept Surg, Chicago, IL 60612 USA
[2] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biometry, Chicago, IL USA
关键词
hereditary hemochromatosis; heterozygosity; hepatoma; diabetes; arthritis; colorectal neoplasia;
D O I
10.1159/000048850
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Parents of hereditary hemochromatosis (HH) homozygote patients, who are predominantly HH heterozygotes, have been found to have an increased risk of colonic neoplasia, diabetes, stroke death, stomach cancer and leukemia. The health histories of siblings of HH patients are reported. Methods: Individuals homozygous for HH were mailed questionnaires concerning the health histories of their siblings. Spouses of the HH homozygotes were asked to complete accompanying questionnaires concerning their siblings. The frequencies of serious illness and, when specified, each reported disease were determined by zygosity, odds ratios and 95% confidence intervals estimated. Results: Data were available for 279 siblings known to be HH homozygotes (HHs), and 1,265 other siblings of HH patients,who are predominantly hemochromatosis heterozygotes (HHhet). Controls consisted of 1,338 spouse siblings in whom only the general population prevalence of HH homozygosity and heterozygosity existed. Odds ratios comparing HH strata to controls were elevated for serious illness (1.12 in HHhet, 1.71 in HHs), diabetes (0.78, 2.45), arthritis (2.10, 1.69), and hepatoma (1.06, 11.96). Conclusions: There was a significant trend for increased risk of serious illness among siblings of HH patients with increasing exposure to the HH gene, especially for diabetes, arthritis and hepatoma. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 20 条
[1]   HEPATOCELLULAR-CARCINOMA IN HEREDITARY HEMOCHROMATOSIS [J].
ADAMS, PC .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 1993, 7 (01) :37-41
[2]  
Altés A, 1999, HAEMATOLOGICA, V84, P479
[3]   Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders [J].
Beckman, LE ;
Van Landeghem, GF ;
Sikström, C ;
Wahlin, A ;
Markevärn, B ;
Hallmans, G ;
Lenner, P ;
Athlin, L ;
Stenling, R ;
Beckman, L .
CARCINOGENESIS, 1999, 20 (07) :1231-1233
[4]   GENETIC HEMOCHROMATOSIS - DISTRIBUTION ANALYSIS OF 6 LABORATORY MEASURES OF IRON-METABOLISM [J].
BORECKI, IB ;
RAO, DC ;
LEMIGNON, L ;
YAOUANQ, J ;
SIMON, M ;
LALOUEL, JM .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1989, 34 (03) :435-441
[5]   Clinical and biochemical abnormalities in people heterozygous for hemochromatosis [J].
Bulaj, ZJ ;
Griffen, LM ;
Jorde, LB ;
Edwards, CQ ;
Kushner, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24) :1799-1805
[6]   Hereditary hemochromatosis - Gene discovery and its implications for population-based screening [J].
Burke, W ;
Thomson, E ;
Khoury, MJ ;
McDonnell, SM ;
Press, N ;
Adams, PC ;
Barton, JC ;
Beutler, E ;
Brittenham, G ;
Buchanan, A ;
Clayton, EW ;
Cogswell, ME ;
Meslin, EM ;
Motulsky, AG ;
Powell, LW ;
Sigal, E ;
Wilfond, BS ;
Collins, FS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (02) :172-178
[7]  
Datz C, 1998, CLIN CHEM, V44, P2429
[8]   The hemochromatosis founder mutation in HLA-H disrupts beta(2)-microglobulin interaction and cell surface expression [J].
Feder, JN ;
Tsuchihashi, Z ;
Irrinki, A ;
Lee, VK ;
Mapa, FA ;
Morikang, E ;
Prass, CE ;
Starnes, SM ;
Wolff, RK ;
Parkkila, S ;
Sly, WS ;
Schatzman, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14025-14028
[9]  
JOUNANOLLE AM, 1998, PREVALENCE C282Y MUT, V41, P195
[10]   BODY IRON STORES AND RISK OF CANCER [J].
KNEKT, P ;
REUNANEN, A ;
TAKKUNEN, H ;
AROMAA, A ;
HELIOVAARA, M ;
HAKULINEN, T .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) :379-382